Explore more Norwegian companies →
COMPANY CARD COMPANY
DICO AS
Wholesale of pharmaceutical and medical goods
29,4 % EBIT margin
FINANCIALS
Financial statements and key figures
Company financial statements
Amount in NOK
| Financial statement item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Currency | NOK | NOK | NOK | NOK | NOK |
| Operating revenue | 109 757 414 | 87 305 245 | 49 905 456 | 56,546,000 | 49,001,000 |
| Operating profit | 32 293 884 | 16 926 591 | 4 661 801 | 13,680,000 | 9,429,000 |
| Net income | 26 069 739 | 13 889 265 | 3 788 963 | 10,671,000 | 7,263,000 |
| Equity | 41 122 926 | 25 679 187 | 11 789 922 | 8,001,000 | 7,930,000 |
| Total assets | 58 843 051 | 57 069 620 | 29 689 050 | 30,168,000 | 38,450,000 |
| Total liabilities | 17 720 125 | 31 390 433 | 17 899 128 | 22,167,000 | 30,521,000 |
| EBIT margin | 29,4 % | 19,4 % | 9,3 % | 24,2 % | 19,2 % |
Historical company accounts in NOK. The source identifies the year. A dash indicates an unavailable amount.
Indicators: equity / assets and EBIT / operating revenue. Midline is 0%, scale −100% to +100%. Not a credit assessment.
Show trend in NOK
Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.
Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.
Sources and conversion basis
Companies and corporate groups are kept separate. The same historical annual exchange rate is used for income statement and balance sheet figures. Missing values are shown as “—”. Actual zero values are retained.
- 2025 · NOK · original-NOK · source version 59d52a447382
- 2024 · NOK · original-NOK · source version a05729dcc9d7
- 2023 · NOK · original-NOK · source version 324b4c4230fd
Expand for more financial statement items. We show items with information in at least one year. “—” means a value is missing for that year.
Income statement13 entries with information
| Financial statement item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating revenue | |||||
| Total sales revenue | 109 708 914 | 87 244 867 | 49 855 456 | 56,546,000 | 49,001,000 |
| Total operating revenue | 109 757 414 | 87 305 245 | 49 905 456 | 56,546,000 | 49,001,000 |
| Operating expenses | |||||
| Wage costs | 10 879 791 | 10 447 038 | 8 739 247 | 7,261,000 | 8,899,000 |
| Total operating expenses | 77 463 530 | 70 378 653 | 45 243 655 | — | — |
| Operating profit | |||||
| Operating income (EBIT) | 32 293 884 | 16 926 591 | 4 661 801 | 13,680,000 | 9,429,000 |
| Financial income | |||||
| Total finance income | 1 204 590 | 890 659 | 238 178 | 85,000 | 1,000 |
| Financial expenses | |||||
| Other interest expense | 59 698 | 137 634 | 39 324 | 54,000 | 119,000 |
| Total finance costs | 59 698 | 137 634 | 39 324 | 73,000 | 119,000 |
| Net finance result | 1 144 892 | 753 025 | 198 854 | — | — |
| Results and tax | |||||
| Income before tax | 33 438 776 | 17 679 616 | 4 860 655 | 13,692,000 | 9,312,000 |
| Tax expense on ordinary income | 7 369 037 | 3 790 351 | 1 071 692 | 3,020,000 | 2,049,000 |
| Net income | 26 069 739 | 13 889 265 | 3 788 963 | 10,671,000 | 7,263,000 |
| Total comprehensive income | 26 069 739 | 13 889 265 | 3 788 963 | — | — |
Balance sheet13 entries with information
| Financial statement item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Financial fixed assets | |||||
| Total non-current assets | 295 087 | 575 722 | 895 147 | 986,000 | 1,438,000 |
| Current assets | |||||
| Total inventory | 6 719 838 | 16 116 540 | 7 286 000 | — | — |
| Total receivables | 23 285 919 | 17 869 830 | 15 066 101 | 10,157,000 | 24,991,000 |
| Total cash and cash equivalents | 28 542 207 | 22 507 528 | 6 441 802 | 10,838,000 | 7,220,000 |
| Total current assets | 58 547 964 | 56 493 898 | 28 793 903 | 29,182,000 | 37,012,000 |
| Total assets | 58 843 051 | 57 069 620 | 29 689 050 | 30,168,000 | 38,450,000 |
| Equity | |||||
| Total paid-in equity | 1 485 000 | 1 485 000 | 1 485 000 | 1,485,000 | 1,485,000 |
| Total retained earnings | 39 637 926 | 24 194 187 | 10 304 922 | 6,516,000 | 6,445,000 |
| Total equity | 41 122 926 | 25 679 187 | 11 789 922 | 8,001,000 | 7,930,000 |
| Provisions and long-term liabilities | |||||
| Total long-term liabilities | — | 0 | 0 | — | — |
| Current liabilities | |||||
| Total current liabilities | 17 720 125 | 31 390 433 | 17 899 128 | 22,167,000 | 30,521,000 |
| Total liabilities | 17 720 125 | 31 390 433 | 17 899 128 | 22,167,000 | 30,521,000 |
| Total | |||||
| Total equity and liabilities | 58 843 051 | 57 069 619 | 29 689 050 | 30,168,000 | 38,450,000 |
Some amounts for 2021 and 2022 come from a financial statements archive and are rounded to the nearest NOK 1,000. The source does not specify reporting dates or whether these figures cover the company or a group.
Reported dividends
| Financial year | Dividends – Income statement | Dividends – Balance sheet | Accounting scope |
|---|---|---|---|
| 2025 | — | — | — |
| 2024 | — | — | — |
| 2023 | — | — | — |
| 2022 | 10 600 000 NOK | 10 600 000 NOK | Not stated |
| 2021 | 7 000 000 NOK | 5 000 000 NOK | Not stated |
| 2020 | 2 000 000 NOK | 2 000 000 NOK | Company financial statements |
Income statement and balance sheet are separate accounting fields and must not be added together. “—” means that no amount is available for the year. It does not mean the amount is zero.
Source: Brønnøysundregistrene
Executive salary
| Financial year | Reported CEO salary |
|---|---|
| 2025 | — |
| 2024 | — |
| 2023 | — |
| 2022 | — |
| 2021 | — |
| 2020 | 597 000 NOK |
“—” means that no amount is available for the year. It does not mean the amount is zero.
Source: Brønnøysundregistrene · Amount in NOK
REGISTRY INFORMATION
Company at a glance
- Industry
- 46.460 · Wholesale of pharmaceutical and medical goods Industry classification: Statistics Norway · CC BY 4.0
- Registered address
- Strandveien 55, 1366 LYSAKER
- Founded
- 02.05.2003
- Entity type
- Main entity
ADDRESS AND PROPERTY
Property information
Strandveien 55, 1366 LYSAKER
Companies at the same address
Available company cards
About the address match
Same registered street address, postal code, and municipality. This does not document ownership, tenancy, or who uses the building. The address match does not identify a specific unit or dwelling. Open information does not show titleholders, sale date, plot area, or a complete building overview.
REGISTERED ROLES
The people and companies behind it.
| Name | Role | Source date |
|---|---|---|
| TALLENT ASView role record | Accountant | 14.11.2026 |
| Robert Andrzej KolakowskiBorn 1973 | Board member | 14.11.2026 |
| RRO ASView role record | Auditor | 14.11.2026 |
| Jan KnophBorn 1961 | Chair of the board | 14.11.2026 |
| Øyvind Rustand DahlBorn 1986 | General manager | 14.11.2026 |
| Øyvind Rustand DahlBorn 1986 | Board member | 14.11.2026 |
Source: Brønnøysund Register Centre. A registered role is not documentation of direct contact information.
YEAR-DATED OWNERSHIP
Reported shareholders.
As of 31 December 2025 · 1 of 1 available ownership entries
| Shareholder | Share / share class | Source date |
|---|---|---|
| ONEMED ASView ownership entryView share entries → | 100,00 % · Ordinary shares | 31.12.2025 |
- ONEMED ASOrdinary shares100,00 %
Fixed scale 0–100%. Shares are not normalized. Any unfilled portion is outside the displayed total.
Source: Skatteetaten. Ownership share is a share of the number of shares, not necessarily voting rights or control. Person names refer to separate source records. Similar names are not automatically the same person.
YEAR-DATED OWNERSHIP
Company share entries
The company’s own investments in other businesses. Shareholders who own the company are shown under Ownership.
Source and scope
Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.
Up to 500 source records examined; the view may be limited. Missing matches do not prove that ownership is absent.
YEAR-DATED OWNERSHIP
Indirect ownership
Explore documented ownership paths through companies. Each path and share class is shown separately; shares are not added together.
Source and scope
Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.
Up to four ownership levels, 32 company lookups, and 250 chains are examined within a short time budget. This is a limited selection, not a ranking of the largest 250. Cycles are stopped. Missing matches do not prove that ownership is absent.
CONNECTIONS
Explore the ownership structure.
Directly reported ownership entries are shown first. Open the map to explore further.
Direct ownership entries without an interactive map
As of 31 December 2025 · 1 of 1 available ownership entries
| Shareholder | Share / share class | Source date |
|---|---|---|
| ONEMED ASView ownership entryView share entries → | 100,00 % · Ordinary shares | 31.12.2025 |
Source: Skatteetaten / Aksjonærregisteret. Year-dated share ownership is not necessarily today’s voting rights or corporate control.
Open interactive map for direct ownership entries
CONNECTIONS
Explore the ownership structure.
See owners and open further company levels, using the same year throughout the tree.
Click a company to open owners. Select i for details.